Weare Health Associates Ltd 14641449 false 2023-02-06 2024-02-29 2024-02-29 The principal activity of the company is that of clinical and support services, utilising technology and data to drive improved decision making in the NHS. Digita Accounts Production Advanced 6.30.9574.0 true true 14641449 2023-02-06 2024-02-29 14641449 2024-02-29 14641449 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 14641449 core:MotorVehicles 2024-02-29 14641449 bus:SmallEntities 2023-02-06 2024-02-29 14641449 bus:AuditExemptWithAccountantsReport 2023-02-06 2024-02-29 14641449 bus:FilletedAccounts 2023-02-06 2024-02-29 14641449 bus:SmallCompaniesRegimeForAccounts 2023-02-06 2024-02-29 14641449 bus:RegisteredOffice 2023-02-06 2024-02-29 14641449 bus:Director1 2023-02-06 2024-02-29 14641449 bus:PrivateLimitedCompanyLtd 2023-02-06 2024-02-29 14641449 core:MotorVehicles 2023-02-06 2024-02-29 14641449 countries:EnglandWales 2023-02-06 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 14641449

Weare Health Associates Ltd

Annual Report and Unaudited Financial Statements

for the Period from 6 February 2023 to 29 February 2024

 

Weare Health Associates Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 4

 

Weare Health Associates Ltd

(Registration number: 14641449)
Balance Sheet as at 29 February 2024

Note

2024
£

Fixed assets

 

Tangible assets

4

16,407

Current assets

 

Cash at bank and in hand

 

18,490

Creditors: Amounts falling due within one year

5

(33,153)

Net current liabilities

 

(14,663)

Net assets

 

1,744

Capital and reserves

 

Called up share capital

100

Retained earnings

1,644

Shareholders' funds

 

1,744

For the financial period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 7 March 2024
 

.........................................
N Weare
Director

 

Weare Health Associates Ltd

Notes to the Unaudited Financial Statements for the Period from 6 February 2023 to 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
7a King Street
Frome
Somerset
BA11 1BH

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Weare Health Associates Ltd

Notes to the Unaudited Financial Statements for the Period from 6 February 2023 to 29 February 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 2.

 

Weare Health Associates Ltd

Notes to the Unaudited Financial Statements for the Period from 6 February 2023 to 29 February 2024

4

Tangible assets

Motor vehicles
 £

Total
£

Cost or valuation

Additions

21,875

21,875

At 29 February 2024

21,875

21,875

Depreciation

Charge for the period

5,468

5,468

At 29 February 2024

5,468

5,468

Net book value

At 29 February 2024

16,407

16,407

5

Creditors

Amounts falling due within one year

2024
£

Due within one year

Taxation and social security

4,585

Other creditors

17,676

Corporation tax

10,892

33,153